All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1222-ZP408 | CCL3 (CCR1 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL3-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP409 | CCL3 (CCR5 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL3-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1808 | CCL3 (CCR1 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL3-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1809 | CCL3 (CCR5 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL3-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-0323-LX345 | Anti-CCL3 VHH(X3XH345) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH345 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX346 | Anti-CCL3 VHH(X3XH346) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH346 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX347 | Anti-CCL3 VHH(X3XH347) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH347 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX348 | Anti-CCL3 VHH(X3XH348) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH348 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX349 | Anti-CCL3 VHH(X3XH349) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH349 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX350 | Anti-CCL3 VHH(X3XH350) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH350 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX351 | Anti-CCL3 VHH(X3XH351) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH351 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX352 | Anti-CCL3 VHH(X3XH352) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH352 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX714 | Anti-CCL3 VHH(X3XH345) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH345 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX715 | Anti-CCL3 VHH(X3XH346) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH346 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX716 | Anti-CCL3 VHH(X3XH347) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH347 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX717 | Anti-CCL3 VHH(X3XH348) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH348 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX718 | Anti-CCL3 VHH(X3XH349) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH349 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX719 | Anti-CCL3 VHH(X3XH350) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH350 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX720 | Anti-CCL3 VHH(X3XH351) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH351 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX721 | Anti-CCL3 VHH(X3XH352) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH352 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX6 | Anti-hCCL3 (AB) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | AB | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION